Singapore, Oct. 13 -- Roche has announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and strengthenHong Kong'srole as a leading hub for life sciences and medical technology in theAsia Pacificregion.

As part of this announcement, Roche will strengthen its presence inHong Kongover the next five years. The collaboration is a joint effort between its Pharmaceutical and Diagnostics divisions, with each providing distinct perspectives and advantages. This commitment reflects Roche's confidence inHong Kong'slong-term potential as a center for medical innovation.

Looking ahead, Roche will continue strengthening its commitment toHong Kong'sscientific landscape and ...